Sollzo invests in healthcare and medicine
We acquire shares and stakes in major pharmaceutical companies, and invest in leading healthcare providers through the construction and ownership of healthcare real estate.
2012: History of the Company
Sollzo was incorporated in the UK in 2012. We started by renting out just three real estate properties. At the end of 2019, the company already owned 852 medical properties in the UK, USA and Canada with a total area of 36.4 MMSF (million square feet).
Today, Sollzo works at the intersection of two powerful and dynamic industries - healthcare and real estate.
As one of the largest real estate investors, we use the power of capital to collaborate with leading providers of medical services, research and medical institutions, innovators and healthcare organizations. Through the provision of leasing and property management services, we make the cost of medical real estate affordable and recoupable for our partners.
In 2015, Sollzo begins investing in the construction of healthcare real estate. At the beginning of 2020, the volume of investments in this sector amounted to more than $ 1.5 billion
Since 2017, our organization began to acquire shares in the largest pharmaceutical companies. Today, the value of these assets is estimated at over $ 891 million.
In 2020, in order to increase investment capital, we launched an online investment project with high interest rates on deposits to attract funds from individuals.
In 2023, the company's capital is expected to increase by 453% compared to 2020 by attracting new investors and entering other market sectors, including the fight against COVID-19.
Sollzo Investment Project
To increase its working capital, in 2020 the company launched an online investment project to attract individuals who do not have significant financial resources to large-scale investment activities
Through the online investment platform Sollzo, private investors from different countries now have the opportunity to invest in the most highly profitable and stable sectors of the health care industry - pharmaceuticals and medical real estate, and by combining their capital into a single network, receive consistently high profit from expensive assets.
The increase in investment capital allows the company to expand its activities and acquire new assets, which entails an increase in dividends and an increase in interest rates for our partners and investors.
Our Diversified Portfolio
Sollzo is a strong and stable company with many years of experience in successfully managing assets in dynamic and challenging market conditions.
When developing and adapting our business strategy, we take into account macroeconomic and social trends in order to provide long-term returns and consistently high returns for the company and investors. Our sustainable diversified portfolio has advantages across all asset classes, such as shares in major pharmaceutical companies and medical real estate.
In 2020, due to the coronavirus pandemic, the demand for medicine increased sharply. People all over the world are concerned about maintaining health and life.
The governments of different countries urgently have to invest huge amounts of money in building up the capacities of the healthcare system and in the development of innovative medical products.
It is already obvious that after overcoming the crisis and in subsequent years, this trend will continue, and the whole XXI century will be the century of rapid development of healthcare, which guarantees a stable position of our company in the long term.
PHARMACEUTICAL MARKET SHARES
A: Acquisition of shares of the biggest pharmaceutical companies
Sollzo acquires shares and stakes in major pharmaceutical companies of the big pharmacy, including dividend aristocrats such as Johnson & Johnson, Pfizer, AbbVie, Roche, Novartis and others, which generate huge cash flow, providing investors with a consistently high profit.
As of December 31, 2019, our company owned shares of pharmaceutical companies with a total value of $ 891 million.
Pharmacology is the most profitable industry and has maintained its leadership for several decades. The volume of the global pharmaceutical market in 2019 amounted to more than 1.4 trillion USD and continued to grow in 2020.
Large pharmaceutical companies with annual revenues of several tens of billions of dollars are able to set high prices for their new innovative drugs and use up to 60% of their profits for paying dividends.
Amid the COVID-19 pandemic, investments in biopharmaceutical companies involved in the development of vaccines and new antiviral drugs have already been provided with global demand and guaranteed ultra-high returns.
B: Healthcare real estate
Investing in leading medical service providers through
property ownerships
Sollzo invests in leading healthcare and healthcare networks, including general hospitals, large multidisciplinary and specialized medical centers, various outpatient facilities, dental surgeries, nursing homes and pension communities.
As of December 31, 2019, Sollzo owned 852 medical properties with a total area of 36.4 MMSF (million square feet) worth a total of about $ 4.8 billion USD.
We focus on partnerships with commercial and government healthcare providers, which occupy a significant market share, are financially sound, and provide high quality medical care.
Our company has provided leasing and asset management services at 24.3 MMSF (million square feet).
Built on a trusting relationship with our tenants, our medical real estate business has grown more than ten times since its inception in 2012.
Investing in a high-quality living environment for
elderly people
Population over 65 in developed countries is growing three times faster than population projections. There is an ever-growing demand for modern, age-adapted premises that allow older people to enjoy a full-fledged lifestyle. As a specialized investor, we create exceptional medical facilities that we would choose for our loved ones.
Sollzo owns residential complexes for the elderly located in the UK, USA and Canada with a total area of 12.2 MMSF (million square feet).
The company invests in industry-leading operators with industry-wide scope and industry-specific skills, each of which is a recognized leader in the care of the elderly.
C: Investing in the construction of health facilities
Sollzo invests in the construction of healthcare real estate.
As of December 31, 2019, the company invested more than $ 1.5 billion USD in the construction of medical real estate.
Investors and customers of medical real estate are government organizations in the UK, USA and Canada, commercial companies and NGOs.
In connection with the COVID-19 pandemic, the number of orders for the construction of hospitals from government agencies has increased.
About 2% of real estate remains in the ownership of the company for the provision of leasing and property management services.
For the construction of health facilities, developers with a narrow specialization are required, since the technical features of medical buildings complicate the process of their construction.
We work with partners who understand the special nature of medical real estate and have expertise in a wide range of projects from nursing homes, retirement communities, nursing homes, medical centers, hospitals and private hospitals.
Our Team
Sollzo's professional team is the best in its class.
Our experienced and close-knit team has created a corporate culture whose core values are reputation and exceptional partnerships.
Sustainable development and corporate responsibility strengthened our strategy and contributed to the growth of the company and increase the income of our investors even in the harsh conditions of the global crisis.
The unity of the team of professionals and the trust of our partners and investors add up to a powerful force that allows the company to steadily move along the path of success.
Officially Registered
Sollzo was officially registered as Sollzo Limited with the number 13350456. Please follow this link
https://find-and-update.company-info...mpany/13350456 to get more information about Sollzo.
